- Arteriovenous Malformations
- Trigeminal Neuralgia
- Cancer
- Brain Metastases
- Others
Gamma Knife Devices Market size valued at USD 17.28 billion in 2021 and expected to reach USD 25.42 billion by 2028, growing at a CAGR of 4.68% during forecast period 2022 to 2028. Gamma knife devices market expected to grow at significant CAGR rate during the forecast period. Market players are expanding their market presence by entering into new markets. For instance, in February 2017, Elekta’s received Medical Devices License from Health Canada for its Leksell Gamma Knife Icon radiosurgery system, the only stereotactic radio surgery SRS system designed specifically to target brain tissue. Product developments and new product launches are market strategies adopted by the market players. Gamma knife is one type of radiological surgery device which acts by focusing on low-dosage gamma radiation from various sources on accurate target. Gamma knife devices are used for treating metastatic brain tumours in brain from the sites like breast, lung, and skin, vascular malformations of brain, acoustic neuromas, meningioma’s tumors on the protective layers of the brain, trigeminal neuralgia causes severe facial pain and epilepsy of temporal lobe.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Gamma knife devices market is propelling by the increase in demand of non-invasive procedures, rise in the prevalence of brain cancers, and rise in ageing of population globally. In addition, high success rate of gamma knife treatment, short recovery period, favorable health insurance policies, high government initiatives, growing awareness on radiation therapy are anticipated to boost the market. However, stringent regulations for the approval of the radiation devices, high cost for gamma knife devices and lack of awareness in developing regions are expected to hinder the market. Gamma knife device many alternative therapies namely cyber knife, linac radiosurgery, conventional brain surgery, proton therapy, and modified linear accelerators. Moreover, lack of skilled healthcare professionals to use the radiation devices and side effects of radiation therapy further hampering the growth of the market.
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
1. Executive Summary |
2. Global Gamma Knifes Market Introduction |
2.1. Global Gamma Knifes Market – Taxonomy |
2.2. Global Gamma Knifes Market –Definitions |
                       2.2.1. Application |
                       2.2.2. Anatomy |
                       2.2.3. End User |
3. Global Gamma Knifes Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Gamma Knifes Market Dynamic Factors - Impact Analysis |
3.6. Global Gamma Knifes Market – Competition Landscape |
3.7. Installed Base Information |
3.8. Start-up Identification |
3.9. Reimbursement Scenario |
4. Global Gamma Knifes Market Analysis, 2017- 2021and Forecast, 2022 – 2028 |
4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue (USD Mn) & Installed Base (Units)) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Gamma Knifes Market, By Application, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue (USD Mn) & Installed Base (Units)) |
5.1. Arteriovenous Malformations |
                       5.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue USD, Mn) |
                       5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
                       5.1.3. Market Opportunity Analysis |
5.2. Trigeminal Neuroglia |
                       5.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue USD, Mn) |
                       5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
                       5.2.3. Market Opportunity Analysis |
5.3. Oncology |
                       5.3.1. Maliganant Tumors |
5.3.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.1.3. Market Opportunity Analysis |
                       5.3.2. Benign Tumors |
5.3.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.3.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.2.3. Market Opportunity Analysis |
5.4. Movement Disorders |
                       5.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue USD, Mn) |
                       5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
                       5.4.3. Market Opportunity Analysis |
5.5. Others |
                       5.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue USD, Mn) |
                       5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
                       5.5.3. Market Opportunity Analysis |
6. Global Gamma Knifes Market Forecast, By Anatomy, 2017 - 2021 and Forecast, 2022 – 2028 |
6.1. Head |
                       6.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue USD, Mn) |
                       6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
                       6.1.3. Market Opportunity Analysis |
6.2. Neck |
                       6.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue USD, Mn) |
                       6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
                       6.2.3. Market Opportunity Analysis |
6.3. Other Body Parts |
                       6.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue USD, Mn) |
                       6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
                       6.3.3. Market Opportunity Analysis |
7. Global Gamma Knifes Market Forecast, By End User, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue (USD Mn) & Installed Base (Units)) |
7.1. Hospitals |
                       7.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue USD, Mn) |
                       7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
                       7.1.3. Market Opportunity Analysis |
7.2. Ambulatory Radiotherapy Centers |
                       7.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue USD, Mn) |
                       7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
                       7.2.3. Market Opportunity Analysis |
7.3. Cancer Research Institutions |
                       7.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue USD, Mn) |
                       7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
                       7.3.3. Market Opportunity Analysis |
7.4. Others |
                       7.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue USD, Mn) |
                       7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
                       7.4.3. Market Opportunity Analysis |
8. Global Gamma Knifes Market Forecast, By Region, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue (USD Mn) & Installed Base (Units)) |
8.1. North America |
                       8.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue (USD Mn) & Installed Base (Units)) |
                       8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
                       8.1.3. Market Opportunity Analysis |
8.2. Europe |
                       8.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue (USD Mn) & Installed Base (Units)) |
                       8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
                       8.2.3. Market Opportunity Analysis |
8.3. Asia-Pacific |
                       8.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue (USD Mn) & Installed Base (Units)) |
                       8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
                       8.3.3. Market Opportunity Analysis |
8.4. Latin America |
                       8.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue (USD Mn) & Installed Base (Units)) |
                       8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
                       8.4.3. Market Opportunity Analysis |
8.5. Middle East and Africa |
                       8.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue (USD Mn) & Installed Base (Units)) |
                       8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
                       8.5.3. Market Opportunity Analysis |
8.6. Global Gamma Knifes Market - Opportunity Analysis Index, By Application, By Anatomy, By End User , and Region, 2022 – 2028 |
9. North America Gamma Knifes Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue (USD Mn) & Installed Base (Units)) |
9.1. Application Analysis 2017 - 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
                       9.1.1. Arteriovenous Malformations |
                       9.1.2. Trigeminal Neurolgia |
                       9.1.3. Oncology |
9.1.3.1. Maliganat Tumors |
9.1.3.2. Benign Tumors |
                       9.1.4. Movement Disorders |
                       9.1.5. Others |
9.2. Anatomy Analysis 2017 - 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
                       9.2.1. Head |
                       9.2.2. Neck |
                       9.2.3. Other Body Parts |
9.3. End User Analysis 2017 - 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
                       9.3.1. Hospitals |
                       9.3.2. Ambulatory Radiotherapy Centers |
                       9.3.3. Cancer research Institutions |
                       9.3.4. Others |
9.4. Country Analysis 2017- 2021and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
                       9.4.1. U.S. |
                       9.4.2. Canada |
9.5. North America Gamma Knifes Market - Opportunity Analysis Index, By Application, By Anatomy, By End User, and Country, 2022 – 2028 |
9.6. North America Gamma Knifes Market Dynamics – Trends |
10. Europe Gamma Knifes Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue (USD Mn) & Installed Base (Units)) |
10.1. Application Analysis 2017 - 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
                     10.1.1. Arteriovenous Malformations |
                     10.1.2. Trigeminal Neurolgia |
                     10.1.3. Oncology |
10.1.3.1. Maliganat Tumors |
10.1.3.2. Benign Tumors |
                     10.1.4. Movement Disorders |
                     10.1.5. Others |
10.2. Anatomy Analysis 2017 - 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
                     10.2.1. Head |
                     10.2.2. Neck |
                     10.2.3. Other Body Parts |
10.3. End User Analysis 2017 - 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
                     10.3.1. Hospitals |
                     10.3.2. Ambulatory Radiotherapy Centers |
                     10.3.3. Cancer research Institutions |
                     10.3.4. Others |
10.4. Country Analysis 2017 - 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
                     10.4.1. Germany |
                     10.4.2. UK |
                     10.4.3. France |
                     10.4.4. Spain |
                     10.4.5. Italy |
                     10.4.6. Russia |
                     10.4.7. Poland |
                     10.4.8. Rest of Europe |
10.5. Europe Gamma Knifes Market - Opportunity Analysis Index, By Application, By Anatomy, By End User, and Country, 2022 – 2028 |
10.6. Europe Gamma Knifes Market Dynamics – Trends |
11. Asia-Pacific Gamma Knifes Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue (USD Mn) & Installed Base (Units)) |
11.1. Application Analysis 2017 - 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
                     11.1.1. Arteriovenous Malformations |
                     11.1.2. Trigeminal Neurolgia |
                     11.1.3. Oncology |
11.1.3.1. Maliganat Tumors |
11.1.3.2. Benign Tumors |
                     11.1.4. Movement Disorders |
                     11.1.5. Others |
11.2. Anatomy Analysis 2017 - 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
                     11.2.1. Head |
                     11.2.2. Neck |
                     11.2.3. Other Body Parts |
11.3. End User Analysis 2017 - 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
                     11.3.1. Hospitals |
                     11.3.2. Ambulatory Radiotherapy Centers |
                     11.3.3. Cancer research Institutions |
                     11.3.4. Others |
11.4. Country Analysis 2017 - 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
                     11.4.1. Japan |
                     11.4.2. China |
                     11.4.3. India |
                     11.4.4. ASEAN |
                     11.4.5. Australia & New Zealand |
                     11.4.6. Rest of Asia-Pacific |
11.5. Asia-Pacific Gamma Knifes Market - Opportunity Analysis Index, By Application, By Anatomy, By End User, and Country, 2022 – 2028 |
11.6. Asia-Pacific Gamma Knifes Market Dynamics – Trends |
12. Latin America Gamma Knifes Market Analysis, 2012 - 2012 - 2017 - 2021 and Forecast, 2022 – 2028 (Revenue (USD Mn) & Installed Base (Units)) |
12.1. Application Analysis 2017 - 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
                     12.1.1. Arteriovenous Malformations |
                     12.1.2. Trigeminal Neurolgia |
                     12.1.3. Oncology |
12.1.3.1. Maliganat Tumors |
12.1.3.2. Benign Tumors |
                     12.1.4. Movement Disorders |
                     12.1.5. Others |
12.2. Anatomy Analysis 2017 - 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
                     12.2.1. Head |
                     12.2.2. Neck |
                     12.2.3. Other Body Parts |
12.3. End User Analysis 2017 - 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
                     12.3.1. Hospitals |
                     12.3.2. Ambulatory Radiotherapy Centers |
                     12.3.3. Cancer research Institutions |
                     12.3.4. Others |
12.4. Country Analysis 2017 - 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
                     12.4.1. Brazil |
                     12.4.2. Mexico |
                     12.4.3. Argentina |
                     12.4.4. Venezuela |
                     12.4.5. Rest of Latin America |
12.5. Latin America Gamma Knifes Market - Opportunity Analysis Index, By Application, By Anatomy, By End User, and Country, 2022 – 2028 |
12.6. Latin America Gamma Knifes Market Dynamics – Trends |
13. Middle East and Africa Gamma Knifes Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 (Revenue (USD Mn) & Installed Base (Units)) |
13.1. Application Analysis 2017 - 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
                     13.1.1. Arteriovenous Malformations |
                     13.1.2. Trigeminal Neurolgia |
                     13.1.3. Oncology |
13.1.3.1. Maliganat Tumors |
13.1.3.2. Benign Tumors |
                     13.1.4. Movement Disorders |
                     13.1.5. Others |
13.2. Anatomy Analysis 2017 - 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
                     13.2.1. Head |
                     13.2.2. Neck |
                     13.2.3. Other Body Parts |
13.3. End User Analysis 2017 - 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
                     13.3.1. Hospitals |
                     13.3.2. Ambulatory Radiotherapy Centers |
                     13.3.3. Cancer research Institutions |
                     13.3.4. Others |
13.4. Country Analysis 2017 - 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
                     13.4.1. Gulf Cooperation Council (GCC) Countries |
                     13.4.2. Israel |
                     13.4.3. South Africa |
                     13.4.4. Rest of MEA |
13.5. MEA Gamma Knifes Market - Opportunity Analysis Index, By Application, By Anatomy, By End User, and Country, 2022 – 2028 |
13.6. MEA Gamma Knifes Market Dynamics – Trends |
14. Competition Landscape |
14.1. Strategic Dashboard of Top Market Players |
14.2. Company Profiles (Introduction, Financial Analysis, Application & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
14.3. Company Share Analysis |
                     14.3.1. Elekta AB. |
                     14.3.2. Varian Medical Systems Inc. |
                     14.3.3. Masep Medical Science & Technology Development (Shenzhen) Co., Ltd. |
                     14.3.4. ET Medical Group (China) |
                     14.3.5. Cyber Medical Systems Inc. |
                     14.3.6. Huiheng Medical Inc. |
15. Research Methodology |
16. Key Assumptions and Acronyms |